BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20423667)

  • 1. [Linezolid therapy for infectious endocarditis].
    Lauridsen TK; Arpi M; Bruun NE
    Ugeskr Laeger; 2010 Apr; 172(16):1215-6. PubMed ID: 20423667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis.
    Berdal JE; Eskesen A
    Scand J Infect Dis; 2008; 40(9):765-6. PubMed ID: 18609208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I; Konkoly TM; Zsirka KA; CsapĆ³ Z; Flautner L; Tihanyi T
    Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of linezolid treatment for enterococcal endocarditis.
    Zimmer SM; Caliendo AM; Thigpen MC; Somani J
    Clin Infect Dis; 2003 Aug; 37(3):e29-30. PubMed ID: 12884185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors.
    Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM
    J Clin Microbiol; 2007 Feb; 45(2):631-5. PubMed ID: 17182759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
    Archuleta S; Murphy B; Keller MJ
    Transpl Infect Dis; 2004 Sep; 6(3):117-9. PubMed ID: 15569227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid.
    Rao N; White GJ
    Clin Infect Dis; 2002 Oct; 35(7):902-4. PubMed ID: 12228838
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
    Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
    de Feiter PW; Jacobs JA; Jacobs MJ; Vink C; van der Geest S
    Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
    Ang JY; Lua JL; Turner DR; Asmar BI
    Pediatr Infect Dis J; 2003 Dec; 22(12):1101-3. PubMed ID: 14688576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience with linesolid usage in newborn children].
    Atanasova V; Slavkova N; Rosmanova R
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
    Tu EY; Jain S
    Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid in the treatment of Gram-positive prosthetic joint infections.
    Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid-based therapy in Staphylococcus epidermidis endocarditis.
    Mylona E; Fanourgiakis P; Vryonis E; Golfinopoulou S; Skoutelis A; Platsouka E; Chatzis N
    Int J Antimicrob Agents; 2007 May; 29(5):597-8. PubMed ID: 17229555
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
    Ruiz ME; Guerrero IC; Tuazon CU
    Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.